Cancers That Do Not Show — on PET-CT
A clear PET-CT scan does not always mean the cancer is absent. Some tumour types use very little glucose — and glucose uptake is exactly what PET-CT measures. For those cancers, a different scan gives more reliable information.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026
- Some cancers are PET-negative — They use little glucose, so the tracer does not accumulate in them even when the disease is active.
- A clear scan is not always reassuring — For certain cancer types, a normal PET-CT has limited diagnostic meaning without a supporting scan.
- Better tools exist — Each PET-negative cancer type has a preferred alternative — PSMA PET, DOTATATE PET, MRI, or radioiodine scan.
- Tissue diagnosis is still required — No imaging, including PET-CT, replaces a biopsy. Imaging shows where; pathology says what.
on Panel
Survival Rate*
Treated
(800+ reviews)
Several cancer types do not appear reliably on PET-CT, even when active. These cancers use very little glucose — which is what PET-CT detects. Prostate cancer, well-differentiated neuroendocrine tumours, certain indolent lymphomas, renal cell carcinoma, and well-differentiated thyroid cancers are the most important examples. Each has a preferred alternative scan.
CION does PET-CT in Hyderabad from Rs 10,499 — among the lowest published prices in the city, with no hidden charges. Indicative price, as of September 2026.
Why do some cancers not show up on PET-CT?
PET-CT works by injecting a radioactive glucose tracer into your body and imaging where it collects. Cancer cells that are growing quickly absorb large amounts of glucose, which makes them visible.
Cancers that grow slowly, or that have a particular cell structure, use very little glucose. The tracer does not accumulate in them, so they do not appear — even when the tumour is present and active.
This is a known limitation of the technology, not a scanning error. Your oncologist selects the imaging method based on your specific cancer type, which is why different patients receive different scans.
Which cancers are commonly not visible on PET-CT?
- Prostate cancerEspecially low-grade and early-stage disease. The PSMA PET scan is now the preferred tool for staging and restaging, recommended by NCCN and ESMO over standard FDG PET-CT.
- Well-differentiated neuroendocrine tumours (carcinoid tumours)Grade 1 and grade 2 NETs have very low glucose uptake. A Ga-68 DOTATATE PET scan is used instead, and is the standard recommended by ENETS and NCCN.
- Low-grade indolent lymphomasFollicular lymphoma, MALT lymphoma, and marginal zone lymphoma are often poorly visible. Aggressive subtypes such as Hodgkin disease and DLBCL are usually PET-avid.
- Renal cell carcinoma (kidney cancer)Glucose is excreted through the kidneys, creating high background signal that obscures tumour uptake. Contrast-enhanced CT or MRI is the standard approach.
- Well-differentiated thyroid cancerPapillary and follicular thyroid cancers usually absorb radioiodine rather than glucose. Radioiodine scans and thyroglobulin blood levels are the preferred monitoring tools.
- Lobular breast cancerThis subtype is less FDG-avid than ductal breast cancer. MRI is more sensitive for lobular disease and is preferred for staging.
- Mucinous tumoursSome colorectal and ovarian cancers with high mucin content appear less clearly on PET. CT or MRI is used to assess size and spread.
- Low-grade brain tumoursThe brain uses large amounts of glucose normally, making it difficult to distinguish tumour from healthy brain tissue. MRI is the primary imaging tool for all brain tumours.
PET-CT Scan Centres in Hyderabad
CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.
PET-CT Centre — Punjagutta
PET-CT Centre — Himayatnagar
PET-CT Centre — Narayanaguda
These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
What does a clear PET-CT mean when your cancer is PET-negative?
If you have one of these cancer types, a clear PET-CT does not confirm the cancer is absent or controlled. It confirms only that this scan did not detect what it is not designed to detect.
Your team will interpret your PET-CT result alongside the appropriate scan for your cancer type, your tumour marker levels, and your biopsy findings. No single test makes the whole picture.
If you have received a report that is confusing you, bring it to your next appointment and ask your oncologist to walk through it in the context of your specific diagnosis. Do not interpret a clear PET-CT as reassurance when your symptoms or other results say otherwise.
What is used instead for PET-negative cancers?
- PSMA PET scan
- A PET scan that uses a tracer targeting prostate-specific membrane antigen rather than glucose. It is significantly more sensitive for prostate cancer than standard FDG PET-CT, and is recommended by NCCN and ESMO for staging and restaging.
- Ga-68 DOTATATE PET
- A PET scan using a tracer that binds to receptors found on neuroendocrine tumour cells. It is the preferred staging and restaging tool for well-differentiated NETs according to ENETS and NCCN guidance.
- Radioiodine scan
- Used for differentiated thyroid cancers. Thyroid cells — including most differentiated thyroid cancer cells — absorb iodine. A radioactive form of iodine is given and then imaged with a gamma camera.
- Contrast-enhanced MRI
- Preferred for brain tumours, lobular breast cancer, liver lesions, and bone marrow assessment. It does not depend on glucose uptake and provides excellent soft-tissue detail.
- Contrast-enhanced CT
- Standard for kidney cancer staging and for following mucinous tumours. It provides precise anatomical information about the size and location of disease without relying on metabolic activity.
- Tumour markers
- Blood tests such as PSA for prostate cancer, thyroglobulin for thyroid cancer, and Chromogranin A for neuroendocrine tumours are used alongside imaging to track disease activity and treatment response.
CION does PET-CT in Hyderabad from Rs 10,499 — among the lowest published prices in the city — including an oncologist-reviewed report and a free Rs 950 consultation. Indicative price, as of September 2026.
Explore 94 more Understanding Your PET-CT Report topics
False Positives, False Negatives & Pitfalls
- Bladder, Kidney and Ureter Activity on PET
- Bone Marrow Uptake After Growth Factor Injections
- Bowel Uptake: Normal, Inflammation or Something Else?
- Brown Fat Uptake: A Common Cause of Confusing Findings
- Does a Suspicious PET Finding Always Need a Biopsy?
- Getting a Second Read of Your PET-CT Images
- How Often Is a PET-CT Scan Wrong?
- Muscle Uptake After Exercise or Injections
- Thymic and Rebound Uptake in Younger Patients
- Uptake After Radiotherapy: Inflammation or Disease?
- Uptake at a Biopsy or Surgery Site
- What Causes a False Negative on a PET Scan?
- What Causes a False Positive on a PET Scan?
- What Happens If Two Scans Disagree?
- Which Cancers Do Not Show Well on PET-CT?
- Why the Brain Always Lights Up on PET
Incidental Findings
- A Second Unrelated Cancer Found on PET-CT
- An Incidental Bone Finding on PET-CT
- An Incidental Breast Finding on PET-CT
- An Incidental Kidney or Adrenal Finding
- An Incidental Liver Lesion on PET-CT
- An Incidental Lung Nodule Found on PET-CT
- An Incidental Prostate Finding on PET-CT
- An Incidental Thyroid Nodule on Your PET Scan
- Do All Incidental Findings Need Investigation?
- Focal Bowel Uptake: Could It Be a Polyp?
- Incidental Findings on a PET-CT Scan: What They Are
- Incidental Heart Findings on a Cancer PET Scan
- The Cost of Chasing an Incidental Finding
- What to Ask Your Doctor About an Incidental Finding
Infection, TB & Inflammation on PET
- Can Tuberculosis Look Like Cancer on a PET Scan?
- Dental Infection and Jaw Uptake on PET
- Fungal Infection and Abscess on PET-CT
- How Long Should You Wait After an Infection Before a PET Scan?
- If It Might Be Infection, What Test Comes Next?
- Inflammation After Injections, Vaccines and Cannulas
- Old Healed TB and Calcified Nodes on PET-CT
- PET-CT for Fever of Unknown Origin
- PET-CT for Suspected Infection in Implants and Prostheses
- PET-CT for Vasculitis and Inflammatory Conditions
- Pneumonia and Recent Chest Infection on PET
- Sarcoidosis on PET-CT: The Great Mimic
- TB or Cancer? How Doctors Tell Them Apart
- Thyroid Uptake on PET: Diffuse vs Focal
Reading Your Report: Core Terms
- 'Cannot Be Excluded' and Other Cautious Phrases
- 'Deauville Score' on a Lymphoma PET Report
- 'FDG Avid': What It Means on Your Report
- 'Hypermetabolic': What the Word Actually Means
- 'Hypometabolic' and 'Photopenic' Findings
- 'Impression' vs 'Findings': Which Section Should You Read?
- 'Interval Change' and 'Stable Since Previous Study'
- 'Krenning Score' on a DOTANOC or DOTATATE Report
- 'Lymphadenopathy' on Your PET Report
- 'Metabolically Active Disease': What It Tells You
- 'Metastasis' and 'Distant Spread' on Your Report
- 'Mildly FDG Avid' vs 'Intensely FDG Avid'
- 'No Abnormal FDG Uptake': Is That a Clear Scan?
- 'Physiological Uptake': Normal Areas That Always Light Up
- 'Residual Disease' vs 'Complete Metabolic Response'
- 'Sub-Centimetre Node' and Why Size Matters on PET
- 'Suspicious for Malignancy': How Certain Is That?
- How Long Does a PET-CT Report Take?
- How to Read Your PET-CT Report: A Section-by-Section Guide
- Should You Read Your Own PET-CT Report Before the Consult?
- TNM Staging on a PET-CT Report
- Why Your Report Mentions the Liver and Blood Pool
Response Assessment Scores & Criteria
- Complete Metabolic Response: What It Means
- Deauville Score 1 to 5: The Lymphoma Scale Explained
- End-of-Treatment PET Scan: What It Decides
- How Doctors Judge Whether Treatment Is Working on PET-CT
- Interim PET Scan During Chemotherapy: Why It Is Done
- Metabolic Response vs Size Response: Why They Differ
- PERCIST Criteria: How Metabolic Response Is Measured
- Partial Metabolic Response: Is That Good Enough?
- Progressive Metabolic Disease: What Happens Next
- RECIST vs PERCIST: Size vs Activity
- Stable Metabolic Disease: Good News or Bad?
- Tumour Flare and Pseudoprogression on PET
- What Is a Deauville 3 and Why Is It Ambiguous?
- Why the Scan Says One Thing and You Feel Another
SUV Values Explained
- Comparing SUV Between Two Scans: Is It Meaningful?
- Does a Higher SUV Mean a More Aggressive Cancer?
- Factors That Change Your SUV Reading
- High SUV but Not Cancer: When the Number Misleads
- Is My SUVmax of 4 High? Reading Your Specific Number
- Low SUV but Still Cancer: The PET-Negative Cancers
- SUV in Non-Cancer Conditions
- SUVmax, SUVmean and SUVpeak: What Is the Difference?
- What Is SUV on a PET Scan?
- What Is a Normal SUV Value?
- What SUV Value Indicates Cancer?
- Why Blood Sugar Changes Your SUV Result
- Why Did My SUV Go Down but Not to Zero?
- Why Did My SUV Go Up After Treatment?
Talk to an oncologist about your scan
Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.
Frequently asked questions
My PET-CT was clear but I still have symptoms. What should I do?
Tell your oncologist about your symptoms at your next appointment, or sooner if they are worsening. A clear PET-CT does not rule out active disease in PET-negative cancer types, and symptoms that persist are information your team needs regardless of what any scan shows. Your oncologist may order a different type of imaging or a tumour marker test better suited to your diagnosis. Do not interpret a clear PET-CT as confirmation that nothing is wrong when you still feel unwell.
Can prostate cancer show on a standard PET-CT at all?
Standard FDG PET-CT has poor sensitivity for prostate cancer, particularly when PSA is low or the disease is low-grade. The PSMA PET scan uses a prostate-specific tracer rather than glucose, and NCCN and ESMO guidance both recommend it over FDG PET-CT for prostate cancer staging and restaging. If you have prostate cancer and a PET scan is being considered, ask your oncologist specifically whether PSMA PET is available and appropriate for your situation.
My doctor ordered an MRI instead of a PET-CT. Does that mean the cancer is more serious?
No. The choice of scan is based on which imaging tool gives the most reliable information for your specific cancer type, not on how advanced the disease is. For brain tumours, lobular breast cancer, and certain liver cancers, MRI gives better information than PET-CT regardless of stage. An MRI being ordered instead of, or alongside, PET-CT is a sign your team is using the right tool for your diagnosis.
Is PSMA PET available at CION?
CION coordinates response-assessment and staging scans with partner imaging centres. Ask your oncologist at your next appointment whether PSMA PET is available through your centre's referral network and whether it is appropriate for your current stage and treatment plan. Availability varies by location, and your treating team will know which centres they work with and what wait times to expect.
Does 'well-differentiated' mean the cancer is not serious?
Well-differentiated means the cancer cells look more like normal cells under a microscope and tend to grow more slowly. In some cases this is associated with a better long-term outlook, but it is not a guarantee, and it does not mean the cancer can be left untreated. Well-differentiated neuroendocrine tumours and thyroid cancers, for example, can still spread and require active management. Your oncologist will explain what your tumour grade means specifically for your cancer type and stage.
What if my cancer type is usually PET-avid but my scan came back clear?
A clear PET-CT in a cancer type that is usually visible on PET — such as Hodgkin lymphoma or DLBCL — is meaningful information and is factored into treatment decisions. However, it is always interpreted alongside your clinical examination, symptoms, and other test results. If there is genuine uncertainty, your oncologist may recommend a biopsy of a previously involved site to confirm what the scan is showing. Never interpret any single scan result in isolation from the rest of your clinical picture.